Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Staphylococcus pyogenes aureus

The dimaleate salt of 5,5-dimethyl-10-(4-methylpiperazino)-10,ll-dihydro-5H-dibenzo[b,/]silepin (45c) exhibited some antibacterial activity in vitro toward Mycobacterium tuberculosis H37Rv (minimum inhibitory concentration 12,5/igml ), Streptococcus -haemolyticus (25/igml ) and Staphylococcus pyogenes aureus (25/igml ) (76CCCC910). [Pg.134]

Staphylococcus pyogenes aureus.... . Boils, abscesses, carbuncles... [Pg.224]

Wachstum von Staphylococcus pyogenes aureus. Recueil Trav. chim. Pays-Bas 57, 747 (1938). [Pg.213]

Gram-positive cocci. Leuconostoc, Micrococcus, Peptococcus, Staphylococcus (S. aureus, boils, infections), Streptococcus (S. pyogenes, scarlet fever, throat infections, S. pneumoniae, pneumonia)... [Pg.7]

PANI-g-chitosan (CS) has been screened for its antimicrobial activity against Staphylococcus epidermidis. Staphylococcus aureus. Staphylococcus pyogenes, Escherichia coli, Candida albicans, Candida tropicalis and Candida krusei. The results of the antimicrobial activity of PANI and PANI-g-CS were assessed based on the average diameter of zones of inhibition (ZOI). The results confirmed that PANI-g-CS has an enhanced antimicrobial activity compared with PANI. PANI and PANI-g-CS also show greater antifungal activity than antimicrobial activity [21]. [Pg.157]

Streptococcus pyogenes Streptococcusfaecalis and Staphylococcus aureus show a markedly greater susceptibihty to its action than Escherichia coli and Pseudomonas aeruginosa (205). Thiram has been used ia disiafectant soaps. [Pg.132]

Bacterial resistance to antibiotics has been recognized since the first drugs were introduced for clinical use. The sulphonamides were introduced in 1935 and approximately 10 years later 20% of clinical isolates of Neisseria gonorrhoeae had become resistant. Similar increases in sulphonamide resistance were found in streptococci, coliforms and other bacteria. Penicillin was first used in 1941, when less than 1 % of Staphylococcus aureus strains were resistant to its action. By 1947,3 8% of hospital strains had acquired resistance and currently over 90% of Staph, aureus isolates are resistant to penicillin. Increasing resistance to antibiotics is a consequence of selective pressure, but the actual incidence of resistance varies between different bacterial species. For example, ampicillin resistance inEscherichia coli, presumably under similar selective pressure as Staph, aureus with penicillin, has remained at a level of 30-40% for mai years with a slow rate of increase. Streptococcus pyogenes, another major pathogen, has remained susceptible to penicillin since its introduction, with no reports of resistance in the scientific literature. Equally, it is well recognized that certain bacteria are unaffected by specific antibiotics. In other words, these bacteria have always been antibiotic-resistant. [Pg.181]

The majority of SSTIs are caused by gram-positive organisms and, less commonly, gram-negative bacteria present on the skin surface. Staphylococcus aureus and Streptococcus pyogenes account for the majority of SSTIs. Community-associated methicillin-resistant S. aureus (CA-MRSA) has recently emerged and it is often isolated in otherwise healthy patients. [Pg.522]

Staphylococcus aureus, Haemophilus influenzae, Streptococcus pyogenes and Pseudomonas aeruginosa are all microorganisms that can cause otitis media. Enterobius vermicularis is a threadworm leading to an infection characterised by itchy anus and the presence of white worms. [Pg.113]

Moderate to severe uncomplicated skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes. 2glV q 12 h 10... [Pg.1489]

In mice infections with pneumococci were influenced very satisfactorily by aristolochic acid I. Rats with wounds infected with Staphylococcus aureus were treated intraperitoneally or orally with aristolochic acid I compared to controls, the treated animals recovered much faster. Rabbits after intravenous application of aristolochic acid I showed an increased antibactericial action of serum (97). Mice infected with bacteria including Staphylococcus aureus, Diphococcus pneumoniae, and Streptococcus pyogenes could be protected by treatment with 50 xg/kg ip of aristolochic acid I (97). [Pg.55]

Staphylococcus aures (penicillin-sensitive) Staphyloccocus aureus (penicillin-resistant) Streptococcus pyogenes Streptococcus pneumoniae Enterococcus faecalis ... [Pg.563]

Skin/skin structure infections Furunculosis, pyoderma and impetigo due to Staphylococcus aureus, S. pyogenes or S. agalactiae. [Pg.333]

Gram-positive (aerobes) Cocci Streptococci, e.g. Streptococcus pyogenes Staphylococci, e.g. Staphylococcus aureus Bacilli Listeria... [Pg.232]

Mupirocin (Bactroban) inhibits a specific enzyme responsible for tRNA synthesis in susceptible bacteria. This drug is used topically to treat skin infections caused by Staphylococcus aureus or Streptococcus pyogenes. Likewise, mupirocin can be administered by nasal spray to treat local colonization of S. aureus in the nasal mucosa. This idea may be especially helpful in preventing systemic infection in individuals such as health care workers who are exposed to an outbreak of resistant strains of S. aureus. Local/topical administration of this drug is well tolerated, although some irritation of the skin may occur during topical use, and cough and respiratory irritation can occur when mupirocin is administered by nasal spray. [Pg.512]

Toxic shock syndrome is a very damaging, often fatal condition caused by toxins from Staphylococcus aureus or Streptococcus pyogenes. First reported in children in 1978, it is manifested by high fever, erythroderma (a skin rash condition), and severe diarrhea.6 Patients may exhibit confusion, hypotension, and tachycardia, and they may go into shock with failure of several organs. Survivors often suffer from skin desquamation (flaky skin). [Pg.399]

Biological activity of the macrolide derived from tylosin against Pasteurella multocida and P. haemolytica (in particular) in vitro and P. multicida (in particular) in vivo has been tested on chicks. Remarkable inhibition of these viruses is obtained. It is also found active against Staphylococcus aureus, Streptococcus pyogenes and pneumoniae, Haemophilus influenzae, Mycoplasma gallisepticum, synoviae, hyorhinis and hyopneumoniae 222... [Pg.358]


See other pages where Staphylococcus pyogenes aureus is mentioned: [Pg.496]    [Pg.496]    [Pg.405]    [Pg.164]    [Pg.27]    [Pg.153]    [Pg.604]    [Pg.4]    [Pg.26]    [Pg.1062]    [Pg.1068]    [Pg.1192]    [Pg.87]    [Pg.200]    [Pg.179]    [Pg.278]    [Pg.57]    [Pg.36]    [Pg.1577]    [Pg.1601]    [Pg.1615]    [Pg.156]    [Pg.287]    [Pg.332]    [Pg.45]    [Pg.50]    [Pg.396]    [Pg.165]   
See also in sourсe #XX -- [ Pg.224 ]




SEARCH



5. aureus

Staphylococcus

Staphylococcus aureus

Staphylococcus pyogenes

© 2024 chempedia.info